David McKinley actually said...

"I want to respond to my good friend, Representative Castor, with regard--she brought up the VA."

"We need a robust biopharma industry, and I think everyone agrees to that, investing in rare diseases."

"Policies like referencing pricing and government price-settings will effectively turn our biopharma industry to a risk-averse, think-inside-the-box-rather-than-outside-the-box commodity industry."

"Where is the justice in that process?"